Concepedia

James M. Boyer

JM

Statistics

Publications

4

Citations

194

H-Index

4

Active since

1994

Affiliations

Celldex Therapeutics (United States)(Current)

James M. Boyer is an author at Celldex Therapeutics (United States) specializing in oncology, immunology, and monoclonal antibodies.

Publications per year

1994–2020

4

Publications

4

Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy

Laura Vitale, Lawrence J. Thomas, Li-Zhen He et al. · Cancer Immunology Immunotherapy · 2018 · 67 citations · Full text

, , +12

DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen-expressing cells.

Bin Wang, Michael Merva, Kesen Dang et al. · PubMed · 1994 · 53 citations

, , +15

Development of a Novel Antibody–Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1

Lawrence J. Thomas, Laura Vitale, Thomas J. O’Neill et al. · Molecular Cancer Therapeutics · 2016 · 45 citations

, , +13

Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy

Laura Vitale, Li-Zhen He, Lawrence J. Thomas et al. · Cancer Immunology Immunotherapy · 2020 · 29 citations · Full text

, , +17

1–4 of 4